Yaghmaei et al. utilize doubly robust causal inference estimators and a large medical data set to evaluate the impact of combining Donepezil and Memantine on five-year survival since initial diagnosis of Alzheimer’s disease patients. A significant benefit to survival is seen when the drugs are combined.
- Ehsan Yaghmaei
- Hongxia Lu
- Cyril Rakovski
